Bill Tasks FDA with Setting Up New Regulatory Pathways
Published March 15, 2013 by OSP
The US Senate has approved a piece of legislation passed earlier this month by the House that would generate new incentives for industry and government officials to prepare and respond to threats and diseases, including a new regulatory pathway of sorts that would facilitate the development and approval of medical countermeasures.
